[go: up one dir, main page]

GB201500427D0 - Method - Google Patents

Method

Info

Publication number
GB201500427D0
GB201500427D0 GBGB1500427.8A GB201500427A GB201500427D0 GB 201500427 D0 GB201500427 D0 GB 201500427D0 GB 201500427 A GB201500427 A GB 201500427A GB 201500427 D0 GB201500427 D0 GB 201500427D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1500427.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1500427.8A priority Critical patent/GB201500427D0/en
Publication of GB201500427D0 publication Critical patent/GB201500427D0/en
Priority to PCT/GB2016/050041 priority patent/WO2016113544A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/10—Production naturally occurring

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1500427.8A 2015-01-12 2015-01-12 Method Ceased GB201500427D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1500427.8A GB201500427D0 (en) 2015-01-12 2015-01-12 Method
PCT/GB2016/050041 WO2016113544A1 (en) 2015-01-12 2016-01-08 Treatment of diseases associated with mitochondrial dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1500427.8A GB201500427D0 (en) 2015-01-12 2015-01-12 Method

Publications (1)

Publication Number Publication Date
GB201500427D0 true GB201500427D0 (en) 2015-02-25

Family

ID=52597477

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1500427.8A Ceased GB201500427D0 (en) 2015-01-12 2015-01-12 Method

Country Status (2)

Country Link
GB (1) GB201500427D0 (en)
WO (1) WO2016113544A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013035101A1 (en) 2011-09-11 2013-03-14 Minovia Therapeutics Ltd. Compositions of functional mitochondria and uses thereof
KR20200096610A (en) * 2017-12-08 2020-08-12 유니버시티 오브 워싱톤 Methods and compositions for detecting and promoting cardiolipin remodeling and cardiomyocyte maturation and related methods for treating mitochondrial dysfunction
CN108103185B (en) * 2018-02-28 2020-06-30 青岛泱深生物医药有限公司 Application of LOC105373420 in diagnosis and treatment of Parkinson's disease
EP3823641A4 (en) * 2018-07-22 2022-05-18 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
JP7586811B2 (en) 2018-07-22 2024-11-19 ミノヴィア セラピューティクス リミテッド Mitochondrial enhancement therapy for kidney disease
US12440515B2 (en) 2018-07-22 2025-10-14 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of brain diseases
WO2020021539A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases
CN109182506B (en) * 2018-10-08 2021-10-08 南京市儿童医院 A serum/plasma exosomal miRNA marker associated with atrial septal congenital heart disease and its application
CN111137863B (en) * 2019-12-31 2021-08-31 聊城鲁西双氧水新材料科技有限公司 Hydrogenation tower catalyst on-line switching method, system and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010040901A1 (en) * 2008-10-07 2010-04-15 Pierre Rustin Alternative oxidase and uses thereof
EP2757157A1 (en) * 2013-01-17 2014-07-23 Ecole Polytechnique Federale de Lausanne (EPFL) Modulation of mitophagy and use thereof

Also Published As

Publication number Publication date
WO2016113544A1 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
GB201516047D0 (en) Method
GB201502645D0 (en) Method
GB201502810D0 (en) Method
GB201518263D0 (en) Method
GB201517450D0 (en) Method
GB201516056D0 (en) Method
GB201501941D0 (en) Method
GB201500427D0 (en) Method
GB201506870D0 (en) Method
GB201507581D0 (en) Method
GB201506869D0 (en) Method
GB201501565D0 (en) Method
GB201518465D0 (en) Method
GB201517386D0 (en) Method
GB201510649D0 (en) Method
GB201509961D0 (en) Method
GB201503792D0 (en) Method
GB201502409D0 (en) Method
GB201506315D0 (en) Method
GB201518850D0 (en) Method
GB201517618D0 (en) Method
GB201517634D0 (en) Method
GB201515921D0 (en) Method
GB201515716D0 (en) Method
GB201515711D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)